BioSpace News Archive

Drug Development

Janssen Pharmaceutical K.K. Release: Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)

May 18, 2012
·
16 min read
Drug Development

Esperance Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer

May 18, 2012
·
4 min read
Pharm Country

Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference

May 18, 2012
·
4 min read
Genetown

CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market

May 18, 2012
·
4 min read
Pharm Country

Quest Diagnostics Inc. Extends Endocrine Diagnostic Menu with New Congenital Adrenal Hyperplasia (CAH) Steroid Screening Panels

May 18, 2012
·
3 min read
Drug Development

Neurocrine Biosciences, Inc. Announces Urocortin 2 Phase II Study Results in Patients With Acute Decompensated Heart Failure

May 18, 2012
·
5 min read
FDA

Digestive Care, Inc. Announces FDA Approval of PERTZYE(TM) (pancrelipase) Delayed-Release Capsules

May 18, 2012
·
2 min read
Pharm Country

Eisai Oncology to Present New Research on Product Portfolio and Pipeline at American Society of Clinical Oncology Annual Meeting

May 18, 2012
·
12 min read
Drug Development

Pharmos Corporation Announces Successful Completion of Proof-of-concept Clinical Trial of Levotofisopam for the Treatment of Gout

May 18, 2012
·
5 min read
Business

Sequenom Inc. Provides Update on Agreement With Coventry Health Care

May 18, 2012
·
4 min read